In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Efficacy of durvalumab for early-stage triple-negative breast

Reducing Racial Disparities in Early Cancer Diagnosis With Blood

Racial disparity in distant recurrence-free survival in localized

Evaluation of breast tumor morphologies from African American and

Racial disparities in survival outcomes among breast cancer

Breast Cancer Study: African Americans Not Experiencing Complete

Recurrence-Free Survival Curve for Black and White Patients by

Pathologic Complete Response as a Surrogate Endpoint in Breast

Routine Genetic Testing of Germline Breast Cancer Susceptibility

The persisting puzzle of racial disparity in triple negative

A Predictor of Pathological Complete Response to Neoadjuvant